Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
(3)
About
Laurus Labs Ltd.
NSE: LAURUSLABS
|
BSE: 540222
|
ISIN: INE947Q01028
|
Industry: Pharmaceuticals
10-year high
|
Strong Performer, Getting Expensive
778.3000
2.05
(
0.26
%)
NSE
Jul 08, 2025
15:31 PM
New 52W High today
Volume:
1.6M
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Laurus Labs Ltd.
30 Apr 2020
10-year high
778.30
0.26%
Laurus Labs (BUY): Good beat; firm FY21 outlook target raised to Rs 630
Buy:
Laurus Labs Ltd.
by
BOB Capital Markets Ltd.
Target: 630
Target
BOB Capital Markets Ltd.
Laurus Labs reported a strong operational beat of 8%/20%/41% on sales/EBITDA/ PBT in Q4.
Laurus Labs Ltd. has an
average target
of 649.60 from 5 brokers.
More from Laurus Labs Ltd.
Recommended
Five stocks to buy from analysts this week - July 08, 2025
The Baseline |
08 Jul 2025, 05:56PM
Market closes higher, Phoenix Mills' residential sales jump 2.4X YoY in Q1FY26
Trendlyne Marketwatch |
08 Jul 2025, 03:56PM
Earnings Call Transcript - Q1FY21 for Laurus Labs
|
31 Jul 2020